Alcami adds solid state characterization capabilities


MORRISVILLE, NC, Sept. 22, 2022 /PRNewswire/ — Alcami, a US pharmaceutical contract development and manufacturing organization (CDMO), today announced the addition of a 12,000 square foot solid state characterization laboratory. The dedicated solid-state research and development suite is co-located within Alcami’s existing Morrisville lab and is part of Alcami’s 675,000 square feet of integrated operations.

“We look forward to supporting our customers in the discovery of new polymorphic, saline and cocrystalline forms and in the development of robust crystallization and formulation processes,” commented Elliott Franco, Ph.D., Vice President of Laboratory Operations. at Alcami. “We have the technical expertise and technologies to provide our customers with a seamless transition from initial characterization to GMP manufacturing and analytical release,” added Dr. Franco.

The expanded lab on Alcami’s RTP campus further increases Alcami’s footprint in North Carolina and complements Alcami’s existing capabilities in the development, manufacturing and testing of sterile and oral solid pharmaceuticals for patients. products at all stages of development.

“Alcami’s new solid-state characterization services, led by Joanna Bis, Ph.D., include a comprehensive suite of capabilities aimed at advancing our customers’ knowledge of their compounds, advancing clinical candidates and expand intellectual property,” commented Timothy Compton, Business Manager at Alcami.

About Alcam:

Alcami is a North Carolina-based contract development and manufacturing organization with over 40 years of experience advancing products through every stage of the development lifecycle. Building on 675,000 square feet across the United States, Alcami serves pharmaceutical and biotechnology companies of all sizes by providing customizable and innovative solutions for analytical development, clinical-to-commercial manufacturing of sterile and oral solids, packaging, microbiology, cGMP biological storage, environmental monitoring and pharmaceutical support services. . Alcami’s private equity includes Madison Dearborn Partners and Ampersand Capital Partners. For more information, visit

Quote View original content to download multimedia:

SOURCEAlcami Corporation


Comments are closed.